CervoMed issues pre-funded warrants to purchase common stock at $0.001 exercise price

CervoMed Inc. filed a Form of Pre-Funded Warrant to Purchase Common Stock with an exercise price of $0.001 per share, issued under securities exemptions. The offering represents a capital raise mechanism typical for development-stage biotech companies seeking non-dilutive financing alternatives.